絞り込み

16242

広告

731件中 1件~20件表示    検索結果をPubMedで見る PubMedで見る

Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48).

[Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?]

A novel risk prediction score in atrial fibrillation for a net clinical outcome from the ENGAGE AF-TIMI 48 randomized clinical trial.

[Vitamin K antagonists : Is their prescription really "medical malpractice" today?]

Effect of major gastrointestinal tract surgery on the absorption and efficacy of direct acting oral anticoagulants (DOACs).

Population Pharmacokinetics of Edoxaban in Japanese Atrial Fibrillation Patients With Severe Renal Impairment.

Atrial fibrillation and heart failure: Factors influencing the choice of oral anticoagulant.

A single and multiple postprandial dose study investigating the pharmacokinetics and pharmacodynamics of edoxaban in healthy Chinese volunteers
.

Perioperative Management of Direct Oral Anticoagulants (DOACs): A Systemic Review.

Non-vitamin K antagonist oral anticoagulants in atrial fibrillation patients with chronic kidney disease: A systematic review and network meta-analysis.

Choosing Non-Vitamin K Antagonist Oral Anticoagulants: Practical Considerations We Need to Know.

Detection of Lupus Anticoagulant in the era of Direct Oral Anticoagulants.

Management of bleeding in patients receiving non-vitamin K antagonists.

Laboratory and Clinical Monitoring of Direct Acting Oral Anticoagulants: What Clinicians Need to Know.

Edoxaban versus enoxaparin for the prevention of venous thromboembolism after total knee or hip arthroplasty: pooled analysis of coagulation biomarkers and primary efficacy and safety endpoints from two phase 3 trials.

New Standards of Care in Ischemic Stroke.

Direct oral anticoagulants and cardiovascular prevention in patients with nonvalvular atrial fibrillation.

Managing transitions from oral factor Xa inhibitors to unfractionated heparin infusions.

Pharmacological management of pulmonary embolism.

Acute management of stroke patients taking non-vitamin K antagonist oral anticoagulants Addressing Real-world Anticoagulant Management Issues in Stroke (ARAMIS) Registry: Design and rationale.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
Sort by
※並べ替えは表示に時間がかかります